
Xlife Sciences AG
SIX:XLS

Xlife Sciences AG?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
17.7
36.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Xlife Sciences AG hold over its rivals?
What risks and challenges
does Xlife Sciences AG face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Xlife Sciences AG.
Provide an overview of the primary business activities
of Xlife Sciences AG.
What unique competitive advantages
does Xlife Sciences AG hold over its rivals?
What risks and challenges
does Xlife Sciences AG face in the near future?
Has there been any significant insider trading activity
in Xlife Sciences AG recently?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Xlife Sciences AG.
Provide P/S
for Xlife Sciences AG.
Provide P/E
for Xlife Sciences AG.
Provide P/OCF
for Xlife Sciences AG.
Provide P/FCFE
for Xlife Sciences AG.
Provide P/B
for Xlife Sciences AG.
Provide EV/S
for Xlife Sciences AG.
Provide EV/GP
for Xlife Sciences AG.
Provide EV/EBITDA
for Xlife Sciences AG.
Provide EV/EBIT
for Xlife Sciences AG.
Provide EV/OCF
for Xlife Sciences AG.
Provide EV/FCFF
for Xlife Sciences AG.
Provide EV/IC
for Xlife Sciences AG.
Show me price targets
for Xlife Sciences AG made by professional analysts.
What are the Revenue projections
for Xlife Sciences AG?
How accurate were the past Revenue estimates
for Xlife Sciences AG?
What are the Net Income projections
for Xlife Sciences AG?
How accurate were the past Net Income estimates
for Xlife Sciences AG?
What are the EPS projections
for Xlife Sciences AG?
How accurate were the past EPS estimates
for Xlife Sciences AG?
What are the EBIT projections
for Xlife Sciences AG?
How accurate were the past EBIT estimates
for Xlife Sciences AG?
Compare the revenue forecasts
for Xlife Sciences AG with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Xlife Sciences AG and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Xlife Sciences AG against its competitors.
Analyze the profit margins
(gross, operating, and net) of Xlife Sciences AG compared to its peers.
Compare the P/E ratios
of Xlife Sciences AG against its peers.
Discuss the investment returns and shareholder value creation
comparing Xlife Sciences AG with its peers.
Analyze the financial leverage
of Xlife Sciences AG compared to its main competitors.
Show all profitability ratios
for Xlife Sciences AG.
Provide ROE
for Xlife Sciences AG.
Provide ROA
for Xlife Sciences AG.
Provide ROIC
for Xlife Sciences AG.
Provide ROCE
for Xlife Sciences AG.
Provide Gross Margin
for Xlife Sciences AG.
Provide Operating Margin
for Xlife Sciences AG.
Provide Net Margin
for Xlife Sciences AG.
Provide FCF Margin
for Xlife Sciences AG.
Show all solvency ratios
for Xlife Sciences AG.
Provide D/E Ratio
for Xlife Sciences AG.
Provide D/A Ratio
for Xlife Sciences AG.
Provide Interest Coverage Ratio
for Xlife Sciences AG.
Provide Altman Z-Score Ratio
for Xlife Sciences AG.
Provide Quick Ratio
for Xlife Sciences AG.
Provide Current Ratio
for Xlife Sciences AG.
Provide Cash Ratio
for Xlife Sciences AG.
What is the historical Revenue growth
over the last 5 years for Xlife Sciences AG?
What is the historical Net Income growth
over the last 5 years for Xlife Sciences AG?
What is the current Free Cash Flow
of Xlife Sciences AG?
Discuss the annual earnings per share (EPS)
trend over the past five years for Xlife Sciences AG.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CH |
![]() |
Xlife Sciences AG
SIX:XLS
|
115.2m CHF | -63.8 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
993.5B USD | 1 215.6 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
148.6B USD | 16.1 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
132.1B USD | 19.4 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
71.2T KRW | 32.3 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
39.1B CHF | 22.6 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
31B USD | 18 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
179.2B CNY | 15.3 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
23.9B USD | 10.4 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
23.2B USD | 20.4 |
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
18.4B EUR | 28.9 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
CH |
![]() |
Xlife Sciences AG
SIX:XLS
|
Average EV/EBITDA:
139.9
|
N/A | N/A | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1 215.6
|
7%
|
173.7 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
16.1
|
6%
|
2.7 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
19.4
|
7%
|
2.8 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
32.3
|
17%
|
1.9 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
22.6
|
18%
|
1.3 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
18
|
10%
|
1.8 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
15.3
|
24%
|
0.6 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
10.4
|
9%
|
1.2 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
20.4
|
4%
|
5.1 |
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
28.9
|
20%
|
1.4 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.